Kimberly-Clark rebounds as analyst cites $120 upside target
2026-07-23 15:28:21
According to CNBC, Jay Woods of Chase Games said Kimberly-Clark is showing signs of a technical rebound and could offer a favorable risk-reward setup after lagging the broader market in recent years. He pointed to the scheduled closing of the $48.7 billion Kenvue deal, which would add Tylenol, Neutrogena and Listerine and could create cost-synergy potential, and said the stock has held above its 50-day and 200-day moving averages and may be close to a golden cross. Woods set downside risk at $95, an initial upside target at $120, and said a move above that level could open the way toward $150.
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
